Similar articles

• [Therapy of community acquired pneumonia].

  Drömann D, Schaaf B. Drömann D, et al. Pneumologie. 2008 Jul;62(7):411-9; quiz 420-2. doi: 10.1055/s-2008-1038139. Pneumologie. 2008. PMID: 18609462 Review. German. No abstract available.
• [Therapy for ambulatory infectious pneumonia].

  Stollewerk D. Stollewerk D. Pneumologie. 2008 Dec;62(12):744; author reply 744. doi: 10.1055/s-2008-1038294. Epub 2008 Dec 2. Pneumologie. 2008. PMID: 19051156 German. No abstract available.
• Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors.

  Schouten JA, Hulscher ME, Kullberg BJ, Cox A, Gyssens IC, van der Meer JW, Grol RP. Schouten JA, et al. J Antimicrob Chemother. 2005 Sep;56(3):575-82. doi: 10.1093/jac/dki275. Epub 2005 Jul 27. J Antimicrob Chemother. 2005. PMID: 16049096
• Community-acquired pneumonia: is it time to shorten the antibiotic treatment?

  Esposito S, Fiore M. Esposito S, et al. Expert Rev Anti Infect Ther. 2007 Dec;5(6):933-8. doi: 10.1586/14787210.5.6.933. Expert Rev Anti Infect Ther. 2007. PMID: 18039078 No abstract available.
• What have we learned about how to measure quality of care for patients with community-acquired pneumonia?

  Metersky ML, Abend SL, Meehan TP. Metersky ML, et al. Respir Care Clin N Am. 2005 Mar;11(1):87-98. doi: 10.1016/j.rcc.2004.10.005. Respir Care Clin N Am. 2005. PMID: 15763224 Review.